Perioperative chemotherapy of bladder cancer. Neoadjuvant, inductive and adjuvant strategies

被引：0

作者：

Lorch, Anja ^{[1
]}

Merseburger, Axel S. ^{[2
]}

Ohlmann, Carsten-Henning ^{[3
]}

机构：

[1] Univ Dusseldorf, Klin Urol, Bereich Konservat Urol Onkol, Moorenstr 5, D-40255 Dusseldorf, Germany

[2] Univ Schleswig Holstein, Klin Urol, Campus Lubeck, Lubeck, Germany

[3] Univ Klinikum Saarlandes, Klin Urol, Homburg, Germany

来源：

ONKOLOGE | 2018年 / 24卷 / 01期

关键词：

Muscle-invasive bladder cancer; Perioperative chemotherapy; Neoadjuvant chemotherapy; Adjuvant chemotherapy; Cystectomy; GEMCITABINE PLUS CISPLATIN; RADICAL CYSTECTOMY; COMBINATION CHEMOTHERAPY; UROTHELIAL CARCINOMA; SURVIVAL; METHOTREXATE; VINBLASTINE; TRIAL;

D O I：

10.1007/s00761-017-0303-x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background. Every year approximately 16,000 patients are diagnosed with muscle-invasive bladder cancer in Germany. The standard procedure in these patients is radical cystectomy with regional pelvic lymphadenectomy. Within the first 2 years after resection up to 50% of patients initially with non-metastatic tumor stages T2-T4a will relapse with lymph node involvement and/or visceral metastases. Methods. Research and analysis of the current literature. Results. To eliminate potential micrometastases the use of perioperative therapeutic concepts in the form of neoadjuvant, inductive and adjuvant chemotherapy is strongly recommended. Despite positive results and high-level evidence from several randomized trials and meta-analyses showing an improved overall survival in favour of bladder cancer patients treated with perioperative chemotherapy, the procedure is currently still underused in Europe. In this review the current data and arguments for and against the various modalities are discussed.

引用

页码：48 / 54

页数：7

共 50 条

[11] Is there an indication for adjuvant or neoadjuvant systemic chemotherapy in bladder cancer? [J].

Suttmann, H. ;

Retz, M. ;

Gschwend, J. E. ;

Stoeckle, M. .

UROLOGE, 2007, 46 (10) :1379-+

[12] Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer [J].

McFerrin, Coleman ;

Davaro, Facundo ;

May, Allison ;

Raza, Syed ;

Siddiqui, Sameer ;

Hamilton, Zachary .

INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (06) :565-572

[13] Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer [J].

Macleod, Liam C. ;

Fam, Mina M. ;

Yabes, Jonathan G. ;

Hale, Nathan E. ;

Turner, Robert M., II ;

Lopa, Samia H. ;

Gingrich, Jeffrey R. ;

Borza, Tudor ;

Skolarus, Ted A. ;

Davies, Benjamin J. ;

Jacobs, Bruce L. .

CLINICAL GENITOURINARY CANCER, 2020, 18 (03) :201-+

[14] Adjuvant chemotherapy in lymph node positive bladder cancer [J].

Gofrit, Ofer N. ;

Stadler, Walter M. ;

Zorn, Kevin C. ;

Lin, Shang ;

Silvestre, Josephine ;

Shalhav, Arieh L. ;

Zagaja, Gregory P. ;

Steinberg, Gary D. .

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2009, 27 (02) :160-164

[15] Adjuvant and neoadjuvant chemotherapy for bladder cancer.: What do we know? [J].

Suttmann, H. ;

Lehmann, J. ;

Stoeckle, M. .

ONKOLOGE, 2007, 13 (12) :1101-+

[16] Which Is the Best Perioperative Chemotherapy for Muscle Invasive Bladder Cancer? [J].

Terrisse, S. ;

Doucet, L. ;

Pouessel, D. ;

Gauthier, H. ;

le Maignan, C. ;

Teixeira, L. ;

Pfister, C. ;

Culine, S. .

ONCOLOGIE, 2015, 17 (04) :165-169

[17] Delivery of perioperative chemotherapy for bladder cancer in routine clinical practice [J].

Booth, C. M. ;

Siemens, D. R. ;

Peng, Y. ;

Tannock, I. F. ;

Mackillop, W. J. .

ANNALS OF ONCOLOGY, 2014, 25 (09) :1783-1788

[18] A prospective study to examine the accuracies and efficacies of prediction systems for response to neoadjuvant chemotherapy for muscle invasive bladder cancer [J].

Kato, Yoichiro ;

Zembutsu, Hitoshi ;

Takata, Ryo ;

Matsuura, Tomohiko ;

Kato, Renpei ;

Kanehira, Mitsugu ;

Iwasaki, Kazuhiro ;

Yamada, Noriyuki ;

Katagiri, Toyomasa ;

Sugai, Tamotsu ;

Fujioka, Tomoaki ;

Nakamura, Yusuke ;

Obara, Wataru .

ONCOLOGY LETTERS, 2018, 16 (05) :5775-5784

[19] Neoadjuvant and Adjuvant Chemotherapy in Muscle-Invasive Bladder Cancer [J].

Calabro, Fabio ;

Sternberg, Cora N. .

EUROPEAN UROLOGY, 2009, 55 (02) :348-358

[20] Cytidine Deaminase Activity Assessment to Select Perioperative Chemotherapy Regimen in Localized Bladder Cancer [J].

Henon, Clemence ;

Huillard, Olivier ;

Preta, Laure-Helene ;

Blanchet, Benoit ;

Goldwasser, Francois ;

Alexandre, Jerome .

CLINICAL GENITOURINARY CANCER, 2017, 15 (03) :E493-E495

← 1 2 3 4 5 →